Franco Dosio
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery 33
- Pharmaceutical Science top 0.5%
- Molecular Medicine top 2%
- Molecular Biology top 5%
- RNA Interference and Gene Delivery 9
- Protein Interaction Studies and Fluorescence Analysis 5
- Pharmacology top 2%
-
- Toxin Mechanisms and Immunotoxins 20
-
- Cancer Treatment and Pharmacology 18
-
- Transgenic Plants and Applications 10
-
- Monoclonal and Polyclonal Antibodies Research 9
-
- Nanoplatforms for cancer theranostics 8
Franco Dosio
101 papers receiving 4.9k citations
Hit Papers
Peers
Comparison fields: 5 of 140
- Biomaterials 1.8k
- Pharmaceutical Science 607
- Molecular Medicine 177
- Molecular Biology 2.1k
- Pharmacology 444
Countries citing papers authored by Franco Dosio
This map shows the geographic impact of Franco Dosio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franco Dosio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franco Dosio more than expected).
Fields of papers citing papers by Franco Dosio
This network shows the impact of papers produced by Franco Dosio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franco Dosio. The network helps show where Franco Dosio may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Franco Dosio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 101 | |
| 2 | 2019 | 10 | |
| 3 | Chapter One - Targeting Human Onchocerciasis: Recent Advances Beyond Ivermectin | 2018 | 1 |
| 4 | 2016 | 47 | |
| 5 | 2015 | 41 | |
| 6 | 2014 | 21 | |
| 7 | 2012 | 15 | |
| 8 | 2012 | 17 | |
| 9 | 2011 | 24 | |
| 10 | 2011 | 27 | |
| 11 | Reactors and strategies to control the particle size distribution of polymeric nanoparticles for pharmaceutical applications | 2008 | 1 |
| 12 | 2005 | 11 | |
| 13 | 2003 | 205 | |
| 14 | 2000 | 69 | |
| 15 | 1999 | 4 | |
| 16 | 1997 | 53 | |
| 17 | 1996 | 6 | |
| 18 | 1994 | 9 | |
| 19 | 1993 | 6 | |
| 20 | 1989 | 11 |
About Franco Dosio
Franco Dosio is a scholar working on Biomaterials, Biotechnology and Pharmaceutical Science, having authored 102 papers that have together received 5.0k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (33 papers), Toxin Mechanisms and Immunotoxins (20 papers), Cancer Treatment and Pharmacology (18 papers), Transgenic Plants and Applications (10 papers), RNA Interference and Gene Delivery (9 papers), Monoclonal and Polyclonal Antibodies Research (9 papers), Nanoplatforms for cancer theranostics (8 papers) and Protein Interaction Studies and Fluorescence Analysis (5 papers). The work is most often cited by research in Biomaterials (1.8k citations), Pharmaceutical Science (607 citations) and Molecular Medicine (177 citations). Franco Dosio has collaborated with scholars based in Italy, France and Belgium. Frequent co-authors include Luigi Cattel, Silvia Arpicco, Barbara Stella, Paola Brusa, Paola Milla, Maurizio Ceruti, Elias Fattal, Natascia Bruni, Paola Crosasso and Carlo Della Pepa. Their work appears in journals such as Journal of Pharmaceutical Sciences, Molecules, Journal of Controlled Release, Bioconjugate Chemistry and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.